Nalaganje...
Euglycemic DKA in Patients on SGLT2 Inhibitor and Potentially Ketotic State
Background: With mounting evidence demonstrating improved cardiovascular and renal outcomes with the use of sodium-glucose cotransporter-2 (SGLT2) inhibitors, this class of newest antidiabetic agents is rapidly gaining favor. SGLT2 inhibition lowers the renal threshold for glucose excretion, resulti...
Shranjeno v:
| izdano v: | J Endocr Soc |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089681/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.779 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|